Release Date: 14/03/24 08:53 Summary: Interim Financial Report Price Sensitive: No Download Document 8.02MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago